2023 Q2 Form 10-Q Financial Statement

#000138584923000015 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $6.863M $19.61M $2.937M
YoY Change 6.12% 567.79% 732.01%
Cost Of Revenue $4.367M $8.266M $2.892M
YoY Change 27.73% 185.82%
Gross Profit $2.496M $11.35M $45.00K
YoY Change -18.11% 25115.56% -87.25%
Gross Profit Margin 36.37% 57.85% 1.53%
Selling, General & Admin $7.458M $6.023M $5.216M
YoY Change 58.58% 15.47% 54.64%
% of Gross Profit 298.8% 53.08% 11591.11%
Research & Development $3.820M $3.100M $1.170M
YoY Change 213.11% 164.96% -65.28%
% of Gross Profit 153.04% 27.32% 2600.0%
Depreciation & Amortization $660.0K $660.0K $813.0K
YoY Change -24.14% -18.82% 6.14%
% of Gross Profit 26.44% 5.82% 1806.67%
Operating Expenses $7.458M $6.023M $5.216M
YoY Change 58.58% 15.47% 54.64%
Operating Profit -$10.66M -$405.0K -$10.21M
YoY Change 58.98% -96.03% 15.44%
Interest Expense $3.020M -$1.580M $9.000K
YoY Change 37650.0% -17655.56% -43.75%
% of Operating Profit
Other Income/Expense, Net $5.778M $114.7M -$4.508M
YoY Change -150.93% -2643.68% 120.22%
Pretax Income -$4.890M $114.3M -$14.73M
YoY Change -72.92% -875.7% 35.01%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$4.885M $114.3M -$14.73M
YoY Change -72.95% -875.7% 35.01%
Net Earnings / Revenue -71.18% 582.57% -501.53%
Basic Earnings Per Share -$0.03 $0.72 -$0.09
Diluted Earnings Per Share -$0.03 $0.72 -$0.09
COMMON SHARES
Basic Shares Outstanding 158.0M shares 157.7M shares 156.6M shares
Diluted Shares Outstanding 158.1M shares 159.2M shares 156.6M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $99.70M $104.3M $105.8M
YoY Change 1.53% -1.42% 139.91%
Cash & Equivalents $35.59M $43.83M $105.2M
Short-Term Investments $64.10M $60.40M $600.0K
Other Short-Term Assets $4.300M $4.500M $2.500M
YoY Change -47.56% 80.0% 31.58%
Inventory $35.11M $40.08M $31.36M
Prepaid Expenses $4.312M $4.198M $2.454M
Receivables $2.400M $2.100M $3.000M
Other Receivables $500.0K $0.00 $700.0K
Total Short-Term Assets $139.9M $148.9M $141.6M
YoY Change 1.47% 5.15% 88.33%
LONG-TERM ASSETS
Property, Plant & Equipment $17.43M $14.64M $21.39M
YoY Change -19.0% -31.56% -8.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $17.40M $16.40M $35.60M
YoY Change -18.31% -53.93% 1447.83%
Other Assets $19.60M $19.60M $22.00M
YoY Change -11.31% -10.91% -0.9%
Total Long-Term Assets $232.1M $226.5M $164.5M
YoY Change 54.4% 37.72% 24.59%
TOTAL ASSETS
Total Short-Term Assets $139.9M $148.9M $141.6M
Total Long-Term Assets $232.1M $226.5M $164.5M
Total Assets $372.1M $375.5M $306.1M
YoY Change 29.08% 22.66% 47.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.585M $1.275M $2.910M
YoY Change -26.59% -56.19% 3.93%
Accrued Expenses $4.000M $4.000M $1.900M
YoY Change 185.71% 110.53% 533.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.569M $5.303M $5.004M
YoY Change 45.98% 5.98% -66.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.40M $11.10M $14.00M
YoY Change -17.99% -20.71% 2.94%
Total Long-Term Liabilities $11.40M $11.10M $14.00M
YoY Change -17.99% -20.71% 2.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.569M $5.303M $5.004M
Total Long-Term Liabilities $11.40M $11.10M $14.00M
Total Liabilities $16.93M $16.44M $19.02M
YoY Change -4.58% -13.58% -33.06%
SHAREHOLDERS EQUITY
Retained Earnings -$346.7M -$341.9M -$411.0M
YoY Change -19.19% -16.82% 0.56%
Common Stock $699.9M $698.8M $690.4M
YoY Change 0.64% 1.22% 18.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $351.2M $355.0M $283.1M
YoY Change
Total Liabilities & Shareholders Equity $372.1M $375.5M $306.1M
YoY Change 29.08% 22.66% 47.72%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.885M $114.3M -$14.73M
YoY Change -72.95% -875.7% 35.01%
Depreciation, Depletion And Amortization $660.0K $660.0K $813.0K
YoY Change -24.14% -18.82% 6.14%
Cash From Operating Activities -$1.380M -$2.579M -$10.55M
YoY Change -87.23% -75.55% 24.89%
INVESTING ACTIVITIES
Capital Expenditures $6.060M $24.84M $400.0K
YoY Change 1854.84% 6110.0% -33.33%
Acquisitions
YoY Change
Other Investing Activities -$350.0K $5.840M $0.00
YoY Change -96.94% -100.0%
Cash From Investing Activities -$6.410M -$19.00M -$398.0K
YoY Change -45.4% 4674.37% -169.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.164M
YoY Change -86.08%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -530.0K -$846.0K $3.590M
YoY Change -113.95% -123.57% -88.19%
NET CHANGE
Cash From Operating Activities -1.380M -$2.579M -$10.55M
Cash From Investing Activities -6.410M -$19.00M -$398.0K
Cash From Financing Activities -530.0K -$846.0K $3.590M
Net Change In Cash -8.320M -$18.93M -$7.337M
YoY Change -55.63% 158.01% -132.55%
FREE CASH FLOW
Cash From Operating Activities -$1.380M -$2.579M -$10.55M
Capital Expenditures $6.060M $24.84M $400.0K
Free Cash Flow -$7.440M -$27.42M -$10.95M
YoY Change -33.09% 150.45% 21.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei City Area Code
CityAreaCode
303
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001385849
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36204
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ENERGY FUELS INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1067994
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
225 Union Blvd., Suite 600
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Lakewood,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80228
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
974-2140
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
158029412 shares
CY2023Q1 efr Revenues Uranium Concentrates
RevenuesUraniumConcentrates
18470000 usd
CY2022Q1 efr Revenues Uranium Concentrates
RevenuesUraniumConcentrates
0 usd
CY2023Q1 efr Revenues Vanadium Concentrates
RevenuesVanadiumConcentrates
871000 usd
CY2022Q1 efr Revenues Vanadium Concentrates
RevenuesVanadiumConcentrates
2412000 usd
CY2023Q1 efr Revenues Alternate Feed Materials Processing And Other
RevenuesAlternateFeedMaterialsProcessingAndOther
272000 usd
CY2022Q1 efr Revenues Alternate Feed Materials Processing And Other
RevenuesAlternateFeedMaterialsProcessingAndOther
525000 usd
CY2023Q1 us-gaap Revenues
Revenues
19613000 usd
CY2022Q1 us-gaap Revenues
Revenues
2937000 usd
CY2023Q1 efr Costof Revenue Uranium Concentrates
CostofRevenueUraniumConcentrates
7715000 usd
CY2022Q1 efr Costof Revenue Uranium Concentrates
CostofRevenueUraniumConcentrates
0 usd
CY2023Q1 efr Cost Of Revenue Vanadium Concentrates
CostOfRevenueVanadiumConcentrates
551000 usd
CY2022Q1 efr Cost Of Revenue Vanadium Concentrates
CostOfRevenueVanadiumConcentrates
1229000 usd
CY2023Q1 efr Underutilized Capacity Production Costs Rare Earth Concentrates
UnderutilizedCapacityProductionCostsRareEarthConcentrates
0 usd
CY2022Q1 efr Underutilized Capacity Production Costs Rare Earth Concentrates
UnderutilizedCapacityProductionCostsRareEarthConcentrates
1663000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
8266000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
2892000 usd
CY2023Q1 efr Exploration Development Permitting And Land Holding
ExplorationDevelopmentPermittingAndLandHolding
3096000 usd
CY2022Q1 efr Exploration Development Permitting And Land Holding
ExplorationDevelopmentPermittingAndLandHolding
1173000 usd
CY2023Q1 efr Standby Costs
StandbyCosts
2287000 usd
CY2022Q1 efr Standby Costs
StandbyCosts
3475000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
346000 usd
CY2022Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
394000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6023000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5216000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-405000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10213000 usd
CY2023Q1 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
116450000 usd
CY2022Q1 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
0 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1781000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4517000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
114669000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4517000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
114264000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14730000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1766000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1766000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
114264000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12964000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
114265000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-14729000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
114264000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14730000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
114265000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12963000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
114264000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12964000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43831000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62820000 usd
CY2023Q1 efr Marketable Securities Debt And Equity Fvni
MarketableSecuritiesDebtAndEquityFVNI
60438000 usd
CY2022Q4 efr Marketable Securities Debt And Equity Fvni
MarketableSecuritiesDebtAndEquityFVNI
12192000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
223000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
223000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
2098000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
519000 usd
CY2023Q1 efr Inventory Current
InventoryCurrent
38003000 usd
CY2022Q4 efr Inventory Current
InventoryCurrent
38155000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4198000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9529000 usd
CY2023Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
346000 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
12375000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
148914000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
135590000 usd
CY2023Q1 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
1501000 usd
CY2022Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
1537000 usd
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
2078000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2465000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1348000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1376000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
16374000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
19329000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14635000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12662000 usd
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
113834000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
83539000 usd
CY2023Q1 efr Debt Securities Convertible Note Fvni
DebtSecuritiesConvertibleNoteFVNI
59259000 usd
CY2022Q4 efr Debt Securities Convertible Note Fvni
DebtSecuritiesConvertibleNoteFVNI
0 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
17508000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
17449000 usd
CY2023Q1 us-gaap Assets
Assets
375451000 usd
CY2022Q4 us-gaap Assets
Assets
273947000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5275000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6929000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
28000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59000 usd
CY2023Q1 efr Contract With Customer Liability Held For Sale Current
ContractWithCustomerLiabilityHeldForSaleCurrent
0 usd
CY2022Q4 efr Contract With Customer Liability Held For Sale Current
ContractWithCustomerLiabilityHeldForSaleCurrent
6000000 usd
CY2023Q1 efr Asset Retirement Obligation And Other Liabilities Held For Sale Current
AssetRetirementObligationAndOtherLiabilitiesHeldForSaleCurrent
0 usd
CY2022Q4 efr Asset Retirement Obligation And Other Liabilities Held For Sale Current
AssetRetirementObligationAndOtherLiabilitiesHeldForSaleCurrent
5636000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5303000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18624000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1273000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1319000 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
9862000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
9595000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
16438000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
29538000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158029412 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
158029412 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
157682531 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
157682531 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
698833000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
698493000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-341855000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-456120000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1946000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1946000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
355032000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
240427000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
3981000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
3982000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359013000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244409000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
375451000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
273947000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244409000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
114264000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1186000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
72000 usd
CY2023Q1 efr Stock Issued During Period Value Cash Paymentfor Tax Withholding
StockIssuedDuringPeriodValueCashPaymentforTaxWithholding
918000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359013000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
295526000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14730000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1766000 usd
CY2022Q1 efr Shares Issued For Cash By At The Market Offering
SharesIssuedForCashByAtTheMarketOffering
4260000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
96000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
862000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
328000 usd
CY2022Q1 efr Stock Issued During Period Value Cash Paymentfor Tax Withholding
StockIssuedDuringPeriodValueCashPaymentforTaxWithholding
884000 usd
CY2022Q1 efr Adjustments To Additional Paid In Capital Shares Issued For Consulting Services
AdjustmentsToAdditionalPaidInCapitalSharesIssuedForConsultingServices
51000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
287083000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
114264000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14730000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
655000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
813000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1186000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
862000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
346000 usd
CY2022Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
394000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 usd
CY2022Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-96000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
24000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1225000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2959000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3418000 usd
CY2023Q1 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
116450000 usd
CY2022Q1 efr Gain On Disposal Of Non Core Assets
GainOnDisposalOfNonCoreAssets
0 usd
CY2023Q1 efr Miscellaneous Non Cash Income Expenses
MiscellaneousNonCashIncomeExpenses
149000 usd
CY2022Q1 efr Miscellaneous Non Cash Income Expenses
MiscellaneousNonCashIncomeExpenses
42000 usd
CY2023Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
325000 usd
CY2022Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
111000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-538000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-784000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1540000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1332000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1233000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
886000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3104000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1123000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2579000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10548000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2042000 usd
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
398000 usd
CY2023Q1 efr Purchase Of Mineral Properties
PurchaseOfMineralProperties
1171000 usd
CY2022Q1 efr Purchase Of Mineral Properties
PurchaseOfMineralProperties
0 usd
CY2023Q1 efr Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
21624000 usd
CY2022Q1 efr Acquisition Of Mineral Properties
AcquisitionOfMineralProperties
0 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
47924000 usd
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
53759000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19002000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-398000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4164000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
918000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
892000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
72000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
318000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-846000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3590000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19000 usd
CY2023Q1 efr Release Of Restricted Cash
ReleaseOfRestrictedCash
-3475000 usd
CY2022Q1 efr Release Of Restricted Cash
ReleaseOfRestrictedCash
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18930000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7337000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80269000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132822000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61339000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125485000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
193000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
11000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
9000 usd
CY2023Q1 efr Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment
IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment
1456000 usd
CY2022Q1 efr Increase Decrease In Accrued Capital Expenditures And Accounts Payable For Property Plant And Equipment
IncreaseDecreaseInAccruedCapitalExpendituresAndAccountsPayableForPropertyPlantAndEquipment
-182000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2876000 usd
CY2023Q1 efr Equity Securities Fvni Gross Unrealized Loss
EquitySecuritiesFVNIGrossUnrealizedLoss
1869000 usd
CY2023Q1 efr Equity Securities Fvni Gross Unrealized Gain
EquitySecuritiesFVNIGrossUnrealizedGain
0 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
1007000 usd
CY2023Q1 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost
121692000 usd
CY2023Q1 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
2067000 usd
CY2023Q1 efr Total Marketable Securities
TotalMarketableSecurities
72000 usd
CY2023Q1 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI
119697000 usd
CY2022Q4 efr Debt Securities Fvni Cost
DebtSecuritiesFVNICost
11435000 usd
CY2022Q4 efr Debt Securities Fvni Gross Unrealized Loss
DebtSecuritiesFVNIGrossUnrealizedLoss
310000 usd
CY2022Q4 efr Debt Securities Fvni Gross Unrealized Gain
DebtSecuritiesFVNIGrossUnrealizedGain
0 usd
CY2022Q4 efr Debt Securities Fvni
DebtSecuritiesFVNI
11125000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2876000 usd
CY2022Q4 efr Equity Securities Fvni Gross Unrealized Loss
EquitySecuritiesFVNIGrossUnrealizedLoss
1809000 usd
CY2022Q4 efr Equity Securities Fvni Gross Unrealized Gain
EquitySecuritiesFVNIGrossUnrealizedGain
0 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
1067000 usd
CY2022Q4 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNICost
14311000 usd
CY2022Q4 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
2119000 usd
CY2022Q4 efr Total Marketable Securities
TotalMarketableSecurities
0 usd
CY2022Q4 efr Debt Securities Available For Sale Held To Maturity And Equity Securities Fvni
DebtSecuritiesAvailableForSaleHeldToMaturityAndEquitySecuritiesFVNI
12192000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
35869000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
35476000 usd
CY2023Q1 efr Inventory Of Ore In Stockpiles
InventoryOfOreInStockpiles
256000 usd
CY2022Q4 efr Inventory Of Ore In Stockpiles
InventoryOfOreInStockpiles
940000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
3956000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4204000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
40081000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
40620000 usd
CY2023Q1 efr Inventory Current
InventoryCurrent
38003000 usd
CY2022Q4 efr Inventory Current
InventoryCurrent
38155000 usd
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
2078000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2465000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
40081000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
40620000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
48464000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33829000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14635000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
45836000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33174000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12662000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
660000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
810000 usd
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
113834000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
83539000 usd
CY2023Q1 efr Number Of Purchase Agreements
NumberOfPurchaseAgreements
2 purchaseagreement
CY2023Q1 efr Purchase Agreement Acres To Purchase
PurchaseAgreementAcresToPurchase
37300 acre
CY2023Q1 efr Purchase Agreement Miles To Purchase
PurchaseAgreementMilesToPurchase
58.3 mi
CY2023Q1 efr Purchase Agreement Purchase Price
PurchaseAgreementPurchasePrice
27500000 usd
CY2023Q1 efr Purchase Agreement Payment Due At Closing
PurchaseAgreementPaymentDueAtClosing
21600000 usd
CY2023Q1 efr Purchase Agreement Deposit Payment
PurchaseAgreementDepositPayment
5900000 usd
CY2023Q1 efr Purchase Agreement Direct Deal Costs
PurchaseAgreementDirectDealCosts
1630000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
9595000 usd
CY2021Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
13687000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 usd
CY2022 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
238000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
346000 usd
CY2022 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
1556000 usd
CY2023Q1 efr Asset Retirement Obligation Held For Sale
AssetRetirementObligationHeldForSale
79000 usd
CY2022Q4 efr Asset Retirement Obligation Held For Sale
AssetRetirementObligationHeldForSale
5410000 usd
CY2023Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
9862000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
9595000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17449000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
20305000 usd
CY2023Q1 efr Additional Collateral Posted
AdditionalCollateralPosted
59000 usd
CY2022 efr Additional Collateral Posted
AdditionalCollateralPosted
734000 usd
CY2023Q1 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
0 usd
CY2022 efr Restricted Cash And Cash Equivalents Held For Sale
RestrictedCashAndCashEquivalentsHeldForSale
3590000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17508000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17449000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
110000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
114265000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14729000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
157930097 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
156614344 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1298970 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159229067 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156614344 shares
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.72
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.72
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
260000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1530000 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1186000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
862000 usd
CY2023Q1 efr Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisable Period
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePeriod
P5Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
767678 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.24
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
120237 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.28
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
34219 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.88
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
17388 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.51
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
836308 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.83
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y2M8D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1767000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
667523 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.99
CY2023Q1 efr Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Instant
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermInstant
P1Y6M21D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1766000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
114260000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2720000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14730000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q1 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-2959000 usd
CY2022Q1 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-3418000 usd
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
325000 usd
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
111000 usd
CY2023Q1 efr Debt Securities Convertible Note Unrealized Gain Loss
DebtSecuritiesConvertibleNoteUnrealizedGainLoss
-198000 usd
CY2022Q1 efr Debt Securities Convertible Note Unrealized Gain Loss
DebtSecuritiesConvertibleNoteUnrealizedGainLoss
0 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
26000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1213000 usd
CY2023Q1 efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
1025000 usd
CY2022Q1 efr Component Of Other Income Expense
ComponentOfOtherIncomeExpense
3000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
114669000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4517000 usd
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
874000 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
92000 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
592000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
0 usd
CY2023Q1 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
343000 usd
CY2022Q4 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
343000 usd
CY2023Q1 efr Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
1790000 usd
CY2022Q4 efr Accounts And Other Receivables Net
AccountsAndOtherReceivablesNet
1621000 usd
CY2023Q1 efr Receivables Net
ReceivablesNet
3599000 usd
CY2022Q4 efr Receivables Net
ReceivablesNet
2056000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
2098000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
519000 usd
CY2023Q1 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
1501000 usd
CY2022Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
1537000 usd
CY2023Q1 efr Receivables Net
ReceivablesNet
3599000 usd
CY2022Q4 efr Receivables Net
ReceivablesNet
2056000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1275000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3224000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1503000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2929000 usd
CY2023Q1 efr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
1038000 usd
CY2022Q4 efr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
22000 usd
CY2023Q1 efr Accrued Property Taxes Current
AccruedPropertyTaxesCurrent
410000 usd
CY2022Q4 efr Accrued Property Taxes Current
AccruedPropertyTaxesCurrent
240000 usd
CY2023Q1 efr Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
761000 usd
CY2022Q4 efr Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
409000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
288000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
105000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5275000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6929000 usd
CY2023Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
162271000 usd
CY2022Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
61857000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
-198000 usd
CY2023Q1 efr Convertible Notes Increase Decrease In Fair Value
ConvertibleNotesIncreaseDecreaseInFairValue
-740000 usd
CY2023Q1 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-2960000 usd
CY2022Q1 efr Change In Value Of Investments Accounted At Fair Value
ChangeInValueOfInvestmentsAccountedAtFairValue
-3420000 usd
CY2023Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
270000 usd
CY2022Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
270000 usd
CY2023Q1 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
270000 usd
CY2022Q1 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
270000 usd

Files In Submission

Name View Source Status
0001385849-23-000015-index-headers.html Edgar Link pending
0001385849-23-000015-index.html Edgar Link pending
0001385849-23-000015.txt Edgar Link pending
0001385849-23-000015-xbrl.zip Edgar Link pending
efr-20230331.htm Edgar Link pending
efr-20230331.xsd Edgar Link pending
efr-20230331_g1.jpg Edgar Link pending
efr3312023-exx231.htm Edgar Link pending
efr3312023-exx311.htm Edgar Link pending
efr3312023-exx312.htm Edgar Link pending
efr3312023-exx321.htm Edgar Link pending
efr3312023-exx322.htm Edgar Link pending
efr3312023-exx951.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
efr-20230331_lab.xml Edgar Link unprocessable
efr-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
efr-20230331_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
efr-20230331_cal.xml Edgar Link unprocessable
efr-20230331_pre.xml Edgar Link unprocessable